An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

J. Kellow, O. Y. Lee, F. Y. Chang, S. Thongsawat, M. Z. Mazlam, H. Yuen, K. A. Gwee, Young-Tae Bak, J. Jones, A. Wagner

    Research output: Contribution to journalArticlepeer-review

    213 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome'. Together they form a unique fingerprint.

    Medicine & Life Sciences